Indivior stock at USD 35.82 on September 25, 2026
Published on 09/28/2026 at 07:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Ahead of the next regular session, Indivior Pharmaceuticals, Inc. shares were last quoted at USD 35.82 on September 25, 2026, at 20:00 UTC. The stock was down USD 0.18, or 0.50 percent, from the previous close on Nasdaq under the ticker INDV.
Reference session
The September 25 quote provides the latest regular-session reference for Indivior stock ahead of the next trading session. The dated share-price information is presented separately from the company's corporate announcements.
Conditional special dividend
On September 17, 2026, Indivior Pharmaceuticals, Inc. announced that its board had declared a special cash dividend of USD 8.13 per share. The dividend would be payable to holders of record on October 30, 2026, subject to the closing of the company's proposed merger with Supernus Pharmaceuticals, Inc.
In its September 17, 2026 filing with the U.S. Securities and Exchange Commission, Indivior said the merger was expected to close on or about November 2, 2026, subject to required stockholder approvals and other closing conditions. Assuming completion on that date, payment to eligible record holders was anticipated on or about November 6, 2026. Indivior said it would not pay the special dividend if the merger was not completed.
